Weiss Multi-Strategy Advisers LLC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 290 filers reported holding MIRATI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,310,000
-55.4%
15,927
-20.5%
0.03%
-54.5%
Q4 2021$2,939,000
+66.1%
20,036
+100.4%
0.07%
+73.7%
Q3 2021$1,769,000
-1.4%
10,000
-10.0%
0.04%
-2.6%
Q2 2021$1,795,000
+779.9%
11,114
+1096.3%
0.04%
+875.0%
Q4 2020$204,000
-59.1%
929
-69.1%
0.00%
-69.2%
Q3 2020$499,000
-64.4%
3,005
-75.6%
0.01%
-67.5%
Q2 2020$1,403,000
-22.6%
12,293
-47.9%
0.04%
-43.7%
Q1 2020$1,813,000
+8.2%
23,584
+81.4%
0.07%
+163.0%
Q4 2019$1,675,00013,0000.03%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders